A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Ossium Health, Inc.
Orca Biosystems, Inc.
Dana-Farber Cancer Institute
Cogent Biosciences, Inc.
Cellenkos, Inc.
University Health Network, Toronto